|
|
||||||||
Eur J Cardiothorac Surg 2000;18:174-181
© 2000 Elsevier Science NL
a Department of Cardiovascular Surgery, Hopital Bichat and Xavier Bichat Medical University, Paris, France
b Institut de Pharmacologie Moléculaire et Cellulaire, CNRS/UPR 411, Valbonne, France
c Department of Anesthesiology, Hopital Bichat, and Xavier Bichat Medical University, Paris, France
Received 20 September 1999; received in revised form 28 February 2000; accepted 7 March 2000.
Corresponding author. Service de Chirurgie Cardio-vasculaire, Centre Hospitalier Universitaire Xavier Bichat, 46 rue henri Huchard, 75018 Paris, France. Tel.: +33-1-4025-8672; fax: +33-1-4025-6700
e-mail: loic.lang{at}wanadoo.fr
Objective: Recent studies confirmed the deleterious role of glutamate in the pathophysiology of spinal cord ischemia induced by aortic cross-clamping. We investigated the effect of riluzole, an anti-glutamate drug, in a rat model of spinal cord ischemia. Materials and methods: Spinal cord ischemia was induced in normothermia for 14 min in SpragueDawley rats using direct aortic arch plus left subclavian artery cross-clamping through a limited thoracotomy. Experimental groups were as follows: sham-operation (n=15), control (n=15) receiving only vehicle, riluzole (n=15) receiving riluzole (4 mg/kg) before clamping and at the onset of reperfusion. Separate animals were used for monitoring physiologic parameters in the sham-operation (n=3), control (n=5), and riluzole (n=5) groups. Neurologic status was assessed at 6, 24 h, and then daily up to 96 h. Rats were randomly killed at 24, 48, or 96 h (n=5 for each time). Spinal cords were harvested for histopathology, immunohistochemistry for microtubule-associated protein 2 (MAP-2), TUNEL staining, and analysis of DNA fragmentation by agarose gel electrophoresis. Results: All sham-operated rats had a normal neurologic outcome, whereas all control rats suffered severe and definitive paraplegia. Riluzole-treated rats had significantly better neurologic function compared to the control. Histopathology disclosed severe neuronal necrosis in the lumbar gray matter of control rats, whereas riluzole-treated rats suffered usually mild to moderate injury. Riluzole particularly prevented motor neurons injury. MAP-2 immunoreactivity was completely lost in control rats, whereas it was preserved either completely or partly in riluzole-treated rats. TUNEL staining revealed numerous apoptotic neurons scattered within the whole gray matter of control rats. Riluzole prevented or dramatically attenuated apoptotic neuronal death in treated rats. DNA extracted from lumbar spinal cords of sham-operated and riluzole-treated rats exhibited no laddering, whereas spinal cords from control rats showed DNA laddering with fragmentation into
180 multiples of base pairs. Conclusions: Riluzole may protect the spinal cord in a setting of severe ischemia by preventing neuronal necrosis and apoptosis. This drug may therefore be considered for clinical use during high risk surgical procedures on the thoracoabdominal aorta.
Key Words: Riluzole Spinal cord ischemia Excitotoxicity Aorta
This article has been cited by other articles:
![]() |
Y. Zhu, P. Fenik, G. Zhan, B. Sanfillipo-Cohn, N. Naidoo, and S. C. Veasey Eif-2a Protects Brainstem Motoneurons in a Murine Model of Sleep Apnea J. Neurosci., February 27, 2008; 28(9): 2168 - 2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Voloshyna, A. Besana, M. Castillo, T. Matos, I. B. Weinstein, M. Mansukhani, R. B. Robinson, C. Cordon-Cardo, and S. J. Feinmark TREK-1 Is a Novel Molecular Target in Prostate Cancer Cancer Res., February 15, 2008; 68(4): 1197 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lang-Lazdunski, J. Bachet, and C. Rogers Repair of the descending thoracic aorta: impact of open distal anastomosis technique on spinal cord perfusion, neurological outcome and spinal cord histopathology Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 351 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xing, Y. Zhang, C. R. Stabernack, E. I Eger II, and A. T. Gray The Use of the Potassium Channel Activator Riluzole to Test Whether Potassium Channels Mediate the Capacity of Isoflurane to Produce Immobility Anesth. Analg., October 1, 2003; 97(4): 1020 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Isbir, K. Ak, O. Kurtkaya, U. Zeybek, S. Akgun, B. W. Scheitauer, A. Sav, and A. Cobanoglu Ischemic preconditioning and nicotinamide in spinal cord protection in an experimental model of transient aortic occlusion Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 1028 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Peasley and R. Shi Resistance of isolated mammalian spinal cord white matter to oxygen-glucose deprivation Am J Physiol Cell Physiol, September 1, 2002; 283(3): C980 - C989. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lang-Lazdunski, C. Heurteaux, H. Dupont, D. Rouelle, C. Widmann, and J. Mantz The Effects of FK506 on Neurologic and Histopathologic Outcome After Transient Spinal Cord Ischemia Induced by Aortic Cross-Clamping in Rats Anesth. Analg., May 1, 2001; 92(5): 1237 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Y.P. Wan, G. D. Angelini, A. J. Bryan, I. Ryder, and M. J. Underwood Prevention of spinal cord ischaemia during descending thoracic and thoracoabdominal aortic surgery Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 203 - 213. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |